Table: Pharmarise Holdings -2025/26 group results
25/06/2026 08:00
Jun 25 (Reuters)-
Pharmarise Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2026 May 31, 2025 May 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 69.51 63.51 70.60 35.18
(+9.5 pct) (+16.6 pct) (+1.6 pct) (+4.7 pct)
Operating 979 mln 293 mln 1.01 359 mln
(+233.5 pct) (-67.9 pct) (+3.5 pct) (-10.0 pct)
Recurring 715 mln 136 mln 736 mln 276 mln
(+422.4 pct) (-83.6 pct) (+2.9 pct) (-16.0 pct)
Net
Net 114 mln loss 367 mln 11 mln loss 44 mln
(-90.0 pct)
EPS 10.01 yen loss 32.48 yen 0.99 yen loss 3.90 yen
EPS Diluted 9.62 yen
Ann Div 14.00 yen 14.00 yen 14.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 14.00 yen 14.00 yen 14.00 yen
NOTE - Pharmarise Holdings Corp.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T